Novartis Institutes for BioMedical Research, Inc.
Methods for treating liver disorders using FXR agonists
The invention provides methods for modulating the activity of farnesoid X receptors (FXRs) using specific FXR agonists, in particular for treating or preventing liver diseases and disorders.
Novartis AG
A A A A A A
A61K A61K A61K A61P A61K A61K
additional inventional inventional inventional inventional inventional
Michael Bryan Sam Jin
Badman Laffitte Lindgren Chen